The Scientific Basis for the Treatment of ALS and Other Neuroregenerative Diseases with Hemealumen Polychromatic Therapy
Presentation Description:
Neurodegenerative diseases such as ALS, Parkinson's disease, Alzheimer's disease, multiple sclerosis, chronic traumatic encephalopathy (CTE), and neurologic Lyme disease share common underlying mechanisms, including mitochondrial dysfunction, oxidative stress, neuroinflammation, impaired circulation, and cellular degeneration. In this presentation, Gene Barnett introduces Hemealumen Polychromatic Therapy, an innovative approach that combines ultraviolet blood irradiation (UVBI) and multi-wavelength photobiomodulation to address these interconnected pathways simultaneously. Attendees will explore the scientific rationale behind this technology, review emerging biomarker and clinical data, and gain insight into how light-based therapies may support neurological function, reduce inflammation, enhance cellular energy production, and potentially improve outcomes in patients facing complex neurodegenerative conditions.